leadf
logo-loader
viewTiziana Life Sciences PLC

Zak Mir talks 'post-crash market environment' and his picks of the recovery stocks

Market Commentator Zak Mir tells Proactive London's Andrew Scott post-crash and mid-lockdown it's all about playing a game of finding the recovery situation.

''There's a few bombed-out ones like AA PLC (LON:AA.), Premier Oil, (LON:PMO) and Tullow (LON:TLW) ... however primary to that are the pharmaceutical stocks ... they're still very much the hottest area in the market''.

''We've had Novacyt (LON:NCYT) and the likes, but various other stocks are coming through as the story develops as to whether it's antibodies we need, testing kits, ventilators and really that's what you should be looking out for''.

''There is a risk the bubble will burst ... If I was trying to be safe then I would probably look for the 'picks and shovels' brigade - the firms providing services to pharma, rather than those trying to come up with a vaccine - and also the treatment side where you've got the likes of Tiziana Life Sciences (LON:TILS)''.

Quick facts: Tiziana Life Sciences PLC

Price: 85 GBX

AIM:TILS
Market: AIM
Market Cap: £165.42 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Tiziana Life Sciences PLC named herein, including the promotion by the Company of Tiziana Life Sciences PLC in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Tiziana Life Sciences to trial 'first ever take-home capsules' of Foralumab...

Tiziana Life Sciences PLC's (LON:TILS) (NASDAQ:TLSA) CEO Kunwar Shailubhai speaks to Proactive's Andrew Scott following the news they're collaborating with Parexel Biotech to conduct a global Phase 1b/2 trial with enteric-coated capsules of formulated Foralumab as a therapy for patients with...

2 weeks, 2 days ago

2 min read